{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:52:14Z","timestamp":1789847534870,"version":"4.0.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["5x1000 10007 and IG 15762"],"award-info":[{"award-number":["5x1000 10007 and IG 15762"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione Golgi (Brescia)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00428-017-2176-1","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T04:35:22Z","timestamp":1499661322000},"page":"467-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases"],"prefix":"10.1007","volume":"471","author":[{"given":"Fabio","family":"Facchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Aldo","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Tabanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rimsza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Dirnhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Copie-Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wotherspoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"key":"2176_CR1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumorus, Lyon"},{"key":"2176_CR2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"JF Emile","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127:2672\u20132681","journal-title":"Blood"},{"key":"2176_CR3","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127:2375\u20132390","journal-title":"Blood"},{"key":"2176_CR4","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3390\/cancers6042275","volume":"6","author":"S Dalia","year":"2014","unstructured":"Dalia S, Jaglal M, Chervenick P, Cualing H, Sokol L (2014) Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years. Cancers (Basel) 6:2275\u20132295","journal-title":"Cancers (Basel)"},{"key":"2176_CR5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/107327481402100405","volume":"21","author":"S Dalia","year":"2014","unstructured":"Dalia S, Shao H, Sagatys E, Cualing H, Sokol L (2014) Dendritic cell and histiocytic neoplasms: biology, diagnosis, and treatment. Cancer Control 21:290\u2013300","journal-title":"Cancer Control"},{"key":"2176_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","volume":"41","author":"SA Pileri","year":"2002","unstructured":"Pileri SA, Grogan TM, Harris NL, Banks P, Campo E, Chan JK, Favera RD, Delsol G, De Wolf-Peeters C, Falini B, Gascoyne RD, Gaulard P, Gatter KC, Isaacson PG, Jaffe ES, Kluin P, Knowles DM, Mason DY, Mori S, Muller-Hermelink HK, Piris MA, Ralfkiaer E, Stein H, Su IJ, Warnke RA, Weiss LM (2002) Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41:1\u201329","journal-title":"Histopathology"},{"key":"2176_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.53.1","volume":"53","author":"E Takahashi","year":"2013","unstructured":"Takahashi E, Nakamura S (2013) Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop 53:1\u20138","journal-title":"J Clin Exp Hematop"},{"key":"2176_CR8","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1182\/blood-2007-11-124792","volume":"111","author":"AL Feldman","year":"2008","unstructured":"Feldman AL, Arber DA, Pittaluga S, Martinez A, Burke JS, Raffeld M, Camos M, Warnke R, Jaffe ES (2008) Clonally related follicular lymphomas and histiocytic\/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 111:5433\u20135439","journal-title":"Blood"},{"key":"2176_CR9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/10428191003699845","volume":"51","author":"E Wang","year":"2010","unstructured":"Wang E, Hutchinson CB, Huang Q, Sebastian S, Rehder C, Kanaly A, Moore J, Datto M (2010) Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular\/genetic evidence suggestive of a \u2018transdifferentiation\u2019 during the clonal evolution. Leuk Lymphoma 51:802\u2013812","journal-title":"Leuk Lymphoma"},{"key":"2176_CR10","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1212\/WNL.0000000000000880","volume":"83","author":"A Idbaih","year":"2014","unstructured":"Idbaih A, Mokhtari K, Emile JF, Galanaud D, Belaid H, de Bernard S, Benameur N, Barlog VC, Psimaras D, Donadieu J, Carpentier C, Martin-Duverneuil N, Haroche J, Feuvret L, Zahr N, Delattre JY, Hoang-Xuan K (2014) Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib. Neurology 83:1478\u20131480","journal-title":"Neurology"},{"key":"2176_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2016.03.007","volume":"73","author":"K Xue","year":"2016","unstructured":"Xue K, Song J, Yang Y, Li Z, Wu C, Jin J, Li W (2016) PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling. Mol Immunol 73:1\u20139","journal-title":"Mol Immunol"},{"key":"2176_CR12","doi-asserted-by":"crossref","first-page":"19819","DOI":"10.18632\/oncotarget.4378","volume":"6","author":"Z Gatalica","year":"2015","unstructured":"Gatalica Z, Bilalovic N, Palazzo JP, Bender RP, Swensen J, Millis SZ, Vranic S, Von Hoff D, Arceci RJ (2015) Disseminated histiocytoses biomarkers beyond BRAF V600E: frequent expression of PD-L1. Oncotarget 6:19819\u201319825","journal-title":"Oncotarget"},{"key":"2176_CR13","doi-asserted-by":"crossref","unstructured":"Balar AV, Weber JS (2017) PD-1 and PD-L1 antibodies in cancer: current status and future directions. Cancer Immunol Immunother","DOI":"10.1007\/s00262-017-1954-6"},{"key":"2176_CR14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/2040620716673787","volume":"8","author":"N Galanina","year":"2017","unstructured":"Galanina N, Kline J, Bishop MR (2017) Emerging role of checkpoint blockade therapy in lymphoma. Ther Adv Hematol 8:81\u201390","journal-title":"Ther Adv Hematol"},{"key":"2176_CR15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.hoc.2015.06.003","volume":"29","author":"M Collin","year":"2015","unstructured":"Collin M, Bigley V, McClain KL, Allen CE (2015) Cell(s) of origin of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 29:825\u2013838","journal-title":"Hematol Oncol Clin North Am"},{"key":"2176_CR16","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2016-08-733790","volume":"128","author":"R Chakraborty","year":"2016","unstructured":"Chakraborty R, Burke TM, Hampton OA, Zinn DJ, Lim KP, Abhyankar H, Scull B, Kumar V, Kakkar N, Wheeler DA, Roy A, Poulikakos PI, Merad M, McClain KL, Parsons DW, Allen CE (2016) Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis. Blood 128:2533\u20132537","journal-title":"Blood"},{"key":"2176_CR17","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","volume":"116","author":"G Badalian-Very","year":"2010","unstructured":"Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116:1919\u20131923","journal-title":"Blood"},{"key":"2176_CR18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/gcc.22247","volume":"54","author":"DS Nelson","year":"2015","unstructured":"Nelson DS, van Halteren A, Quispel WT, van den Bos C, Bovee JV, Patel B, Badalian-Very G, van Hummelen P, Ducar M, Lin L, MacConaill LE, Egeler RM, Rollins BJ (2015) MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis. Genes Chromosomes Cancer 54:361\u2013368","journal-title":"Genes Chromosomes Cancer"},{"key":"2176_CR19","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood-2013-06-511139","volume":"123","author":"DS Nelson","year":"2014","unstructured":"Nelson DS, Quispel W, Badalian-Very G, van Halteren AG, van den Bos C, Bovee JV, Tian SY, Van Hummelen P, Ducar M, MacConaill LE, Egeler RM, Rollins BJ (2014) Somatic activating ARAF mutations in Langerhans cell histiocytosis. Blood 123:3152\u20133155","journal-title":"Blood"},{"key":"2176_CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.2013097701202015c","volume":"212","author":"ML Berres","year":"2015","unstructured":"Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, Beltrao M, Lira SA, Heym KM, Clausen BE, Bigley V, Collin M, Manz MG, McClain K, Merad M, Allen CE (2015) BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med 212:281","journal-title":"J Exp Med"},{"key":"2176_CR21","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.humpath.2007.03.015","volume":"38","author":"M Edelweiss","year":"2007","unstructured":"Edelweiss M, Medeiros LJ, Suster S, Moran CA (2007) Lymph node involvement by Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical study of 20 cases. Hum Pathol 38:1463\u20131469","journal-title":"Hum Pathol"},{"key":"2176_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(06)54001-X","volume":"254","author":"GI Bechan","year":"2006","unstructured":"Bechan GI, Egeler RM, Arceci RJ (2006) Biology of Langerhans cells and Langerhans cell histiocytosis. Int Rev Cytol 254:1\u201343","journal-title":"Int Rev Cytol"},{"key":"2176_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(00)80160-0","volume":"12","author":"J Valladeau","year":"2000","unstructured":"Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y, Duvert-Frances V, Vincent C, Schmitt D, Davoust J, Caux C, Lebecque S, Saeland S (2000) Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12:71\u201381","journal-title":"Immunity"},{"key":"2176_CR24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.0022-202X.2005.23645.x","volume":"124","author":"P Verdijk","year":"2005","unstructured":"Verdijk P, Dijkman R, Plasmeijer EI, Mulder AA, Zoutman WH, Mieke Mommaas A, Tensen CP (2005) A lack of Birbeck granules in Langerhans cells is associated with a naturally occurring point mutation in the human Langerin gene. J Invest Dermatol 124:714\u2013717","journal-title":"J Invest Dermatol"},{"key":"2176_CR25","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2015-07-655530","volume":"126","author":"RA Brown","year":"2015","unstructured":"Brown RA, Kwong BY, McCalmont TH, Ragsdale B, Ma L, Cheung C, Rieger KE, Arber DA, Kim J (2015) ETV3-NCOA2 in indeterminate cell histiocytosis: clonal translocation supports sui generis. Blood 126:2344\u20132345","journal-title":"Blood"},{"key":"2176_CR26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.anndiagpath.2015.02.008","volume":"19","author":"DP O'Malley","year":"2015","unstructured":"O'Malley DP, Agrawal R, Grimm KE, Hummel J, Glazyrin A, Dim DC, Madhusudhana S, Weiss LM (2015) Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma. Ann Diagn Pathol 19:113\u2013116","journal-title":"Ann Diagn Pathol"},{"key":"2176_CR27","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/PAS.0000000000000678","volume":"40","author":"AM Stowman","year":"2016","unstructured":"Stowman AM, Mills SE, Wick MR (2016) Spindle cell melanoma and interdigitating dendritic cell sarcoma: do they represent the same process? Am J Surg Pathol 40:1270\u20131279","journal-title":"Am J Surg Pathol"},{"key":"2176_CR28","doi-asserted-by":"crossref","unstructured":"Magro CM, Olson LC, Nuovo G, Solomon GJ (2017) Primary cutaneous interdigitating dendritic cell sarcoma is a morphologic and phenotypic simulator of poorly differentiated metastatic melanoma: a report of 2 cases and review of the literature. Ann Diagn Pathol","DOI":"10.1016\/j.anndiagpath.2017.02.008"},{"key":"2176_CR29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.anndiagpath.2013.10.003","volume":"18","author":"DP O'Malley","year":"2014","unstructured":"O'Malley DP, Zuckerberg L, Smith LB, Barry TS, Gunn S, Tam W, Orazi A, Kim YS, Weiss LM (2014) The genetics of interdigitating dendritic cell sarcoma share some changes with Langerhans cell histiocytosis in select cases. Ann Diagn Pathol 18:18\u201320","journal-title":"Ann Diagn Pathol"},{"key":"2176_CR30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/his.12416","volume":"65","author":"H Go","year":"2014","unstructured":"Go H, Jeon YK, Huh J, Choi SJ, Choi YD, Cha HJ, Kim HJ, Park G, Min S, Kim JE (2014) Frequent detection of BRAF (V600E) mutations in histiocytic and dendritic cell neoplasms. Histopathology 65:261\u2013272","journal-title":"Histopathology"},{"key":"2176_CR31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.semdp.2016.05.002","volume":"33","author":"F Facchetti","year":"2016","unstructured":"Facchetti F, Lorenzi L (2016) Follicular dendritic cells and related sarcoma. Semin Diagn Pathol 33:159\u2013166","journal-title":"Semin Diagn Pathol"},{"key":"2176_CR32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/COC.0b013e31824be22b","volume":"36","author":"SM Perkins","year":"2013","unstructured":"Perkins SM, Shinohara ET (2013) Interdigitating and follicular dendritic cell sarcomas: a SEER analysis. Am J Clin Oncol 36:395\u2013398","journal-title":"Am J Clin Oncol"},{"key":"2176_CR33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.critrevonc.2013.05.006","volume":"88","author":"C Saygin","year":"2013","unstructured":"Saygin C, Uzunaslan D, Ozguroglu M, Senocak M, Tuzuner N (2013) Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series. Crit Rev Oncol Hematol 88:253\u2013271","journal-title":"Crit Rev Oncol Hematol"},{"key":"2176_CR34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3960\/jslrt.53.179","volume":"53","author":"H Ohtake","year":"2013","unstructured":"Ohtake H, Yamakawa M (2013) Interdigitating dendritic cell sarcoma and follicular dendritic cell sarcoma: histopathological findings for differential diagnosis. J Clin Exp Hematop 53:179\u2013184","journal-title":"J Clin Exp Hematop"},{"key":"2176_CR35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.humpath.2011.02.029","volume":"43","author":"L Lorenzi","year":"2012","unstructured":"Lorenzi L, Lonardi S, Petrilli G, Tanda F, Bella M, Laurino L, Rossi G, Facchetti F (2012) Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders. Hum Pathol 43:209\u2013215","journal-title":"Hum Pathol"},{"key":"2176_CR36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/path.2420","volume":"216","author":"W Vermi","year":"2008","unstructured":"Vermi W, Lonardi S, Bosisio D, Uguccioni M, Danelon G, Pileri S, Fletcher C, Sozzani S, Zorzi F, Arrigoni G, Doglioni C, Ponzoni M, Facchetti F (2008) Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma. J Pathol 216:356\u2013364","journal-title":"J Pathol"},{"key":"2176_CR37","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/PAS.0b013e31819287b8","volume":"33","author":"W Chen","year":"2009","unstructured":"Chen W, Lau SK, Fong D, Wang J, Wang E, Arber DA, Weiss LM, Huang Q (2009) High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic\/dendritic cell sarcomas. Am J Surg Pathol 33:863\u2013873","journal-title":"Am J Surg Pathol"},{"key":"2176_CR38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/modpathol.2015.130","volume":"29","author":"GK Griffin","year":"2016","unstructured":"Griffin GK, Sholl LM, Lindeman NI, Fletcher CD, Hornick JL (2016) Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-kappaB regulatory genes. Mod Pathol 29:67\u201374","journal-title":"Mod Pathol"},{"key":"2176_CR39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejca.2016.06.004","volume":"64","author":"S Hartmann","year":"2016","unstructured":"Hartmann S, Doring C, Agostinelli C, Portscher-Kim SJ, Lonardi S, Lorenzi L, Fuligni F, Martinez D, Mehta J, Borges A, Hackstein H, Kippenberger S, Piccaluga PP, Simonitsch-Klupp I, Cabecadas J, Campo E, Facchetti F, Pileri SA, Hansmann ML (2016) miRNA expression profiling divides follicular dendritic cell sarcomas into two groups, related to fibroblasts and myopericytomas or Castleman\u2019s disease. Eur J Cancer 64:159\u2013166","journal-title":"Eur J Cancer"},{"key":"2176_CR40","doi-asserted-by":"crossref","unstructured":"Laginestra MA, Tripodo C, Agostinelli C, Motta G, Hartmann S, Doring C, Rossi M, Melle F, Sapienza MR, Tabanelli V, Pileri A, Fuligni F, Gazzola A, Mannu C, Sagramoso CA, Lonardi S, Lorenzi L, Bacci F, Sabattini E, Borges A, Simonitsch-Klupp I, Cabecadas J, Campo E, Rosai J, Hansmann ML, Facchetti F, Pileri SA (2017) Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of follicular dendritic cell sarcomas. Mol Cancer Res","DOI":"10.1158\/1541-7786.MCR-16-0301"},{"key":"2176_CR41","doi-asserted-by":"crossref","unstructured":"Lorenzi L, Doring C, Rausch T, Benes V, Lonardi S, Bugatti M, Campo E, Cabecadas J, Simonitsch-Klupp I, Borges A, Mehta J, Agostinelli C, Pileri SA, Facchetti F, Hansmann ML, Hartmann S (2017) Identification of novel follicular dendritic cell sarcoma markers, FDCSP and SRGN, by whole transcriptome sequencing. Oncotarget","DOI":"10.18632\/oncotarget.14864"},{"key":"2176_CR42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.humpath.2012.10.005","volume":"44","author":"SA Rezk","year":"2013","unstructured":"Rezk SA, Nathwani BN, Zhao X, Weiss LM (2013) Follicular dendritic cells: origin, function, and different disease-associated patterns. Hum Pathol 44:937\u2013950","journal-title":"Hum Pathol"},{"key":"2176_CR43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3960\/jslrt.53.57","volume":"53","author":"H Kawabata","year":"2013","unstructured":"Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, Kinoshita T, Masaki Y (2013) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop 53:57\u201361","journal-title":"J Clin Exp Hematop"},{"key":"2176_CR44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clml.2015.06.008","volume":"15","author":"PL Zinzani","year":"2015","unstructured":"Zinzani PL, Corradini P, Gianni AM, Federico M, Santoro A, Vitolo U, Barosi G, Tura S (2015) Brentuximab vedotin in CD30-positive lymphomas: a SIE, SIES, and GITMO position paper. Clin Lymphoma Myeloma Leuk 15:507\u2013513","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2176_CR45","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2014-04-570937","volume":"124","author":"JF Emile","year":"2014","unstructured":"Emile JF, Diamond EL, Helias-Rodzewicz Z, Cohen-Aubart F, Charlotte F, Hyman DM, Kim E, Rampal R, Patel M, Ganzel C, Aumann S, Faucher G, Le Gall C, Leroy K, Colombat M, Kahn JE, Trad S, Nizard P, Donadieu J, Taly V, Amoura Z, Abdel-Wahab O, Haroche J (2014) Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease. Blood 124:3016\u20133019","journal-title":"Blood"},{"key":"2176_CR46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","volume":"6","author":"EL Diamond","year":"2016","unstructured":"Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, Wang Z, Choi J, Kim E, Cohen-Aubart F, Lee SC, Gao Y, Micol JB, Campbell P, Walsh MP, Sylvester B, Dolgalev I, Aminova O, Heguy A, Zappile P, Nakitandwe J, Ganzel C, Dalton JD, Ellison DW, Estrada-Veras J, Lacouture M, Gahl WA, Stephens PJ, Miller VA, Ross JS, Ali SM, Briggs SR, Fasan O, Block J, Heritier S, Donadieu J, Solit DB, Hyman DM, Baselga J, Janku F, Taylor BS, Park CY, Amoura Z, Dogan A, Emile JF, Rosen N, Gruber TA, Abdel-Wahab O (2016) Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov 6:154\u2013165","journal-title":"Cancer Discov"},{"key":"2176_CR47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/bloodadvances.2016001784","volume":"1","author":"JI Estrada-Veras","year":"2017","unstructured":"Estrada-Veras JI, O\u2019Brien KJ, Boyd LC, Dave RH, Durham BH, Xi L, Malayeri AA, Chen MJ, Gardner PJ, Alvarado Enriquez JR, Shah N, Abdel-Wahab O, Gochuico BR, Raffeld M, Jaffe ES, Gahl WA (2017) The clinical spectrum of Erdheim-Chester disease: an observational cohort study. Blood Adv 1:357\u2013366","journal-title":"Blood Adv"},{"key":"2176_CR48","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJMcpc0804623","volume":"359","author":"JA Mills","year":"2008","unstructured":"Mills JA, Gonzalez RG, Jaffe R (2008) Case records of the Massachusetts General Hospital. Case 25-2008. A 43-year-old man with fatigue and lesions in the pituitary and cerebellum. N Engl J Med 359:736\u2013747","journal-title":"N Engl J Med"},{"key":"2176_CR49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2141.1995.tb05313.x","volume":"91","author":"M Paulli","year":"1995","unstructured":"Paulli M, Bergamaschi G, Tonon L, Viglio A, Rosso R, Facchetti F, Geerts ML, Magrini U, Cazzola M (1995) Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Br J Haematol 91:415\u2013418","journal-title":"Br J Haematol"},{"key":"2176_CR50","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12105-016-0709-6","volume":"10","author":"V Shanmugam","year":"2016","unstructured":"Shanmugam V, Margolskee E, Kluk M, Giorgadze T, Orazi A (2016) Rosai-Dorfman disease harboring an activating KRAS K117N missense mutation. Head Neck Pathol 10:394\u2013399","journal-title":"Head Neck Pathol"},{"key":"2176_CR51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000833","volume":"6","author":"NV Morgan","year":"2010","unstructured":"Morgan NV, Morris MR, Cangul H, Gleeson D, Straatman-Iwanowska A, Davies N, Keenan S, Pasha S, Rahman F, Gentle D, Vreeswijk MP, Devilee P, Knowles MA, Ceylaner S, Trembath RC, Dalence C, Kismet E, Koseoglu V, Rossbach HC, Gissen P, Tannahill D, Maher ER (2010) Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease. PLoS Genet 6:e1000833","journal-title":"PLoS Genet"},{"key":"2176_CR52","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/01.pas.0000157997.61177.08","volume":"29","author":"I Maric","year":"2005","unstructured":"Maric I, Pittaluga S, Dale JK, Niemela JE, Delsol G, Diment J, Rosai J, Raffeld M, Puck JM, Straus SE, Jaffe ES (2005) Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol 29:903\u2013911","journal-title":"Am J Surg Pathol"},{"key":"2176_CR53","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2008-03-147017","volume":"112","author":"JK Chan","year":"2008","unstructured":"Chan JK, Lamant L, Algar E, Delsol G, Tsang WY, Lee KC, Tiedemann K, Chow CW (2008) ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood 112:2965\u20132968","journal-title":"Blood"},{"key":"2176_CR54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/modpathol.2015.145","volume":"29","author":"F Facchetti","year":"2016","unstructured":"Facchetti F, Cigognetti M, Fisogni S, Rossi G, Lonardi S, Vermi W (2016) Neoplasms derived from plasmacytoid dendritic cells. Mod Pathol 29:98\u2013111","journal-title":"Mod Pathol"},{"key":"2176_CR55","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/modpathol.2013.238","volume":"27","author":"NA Sangle","year":"2014","unstructured":"Sangle NA, Schmidt RL, Patel JL, Medeiros LJ, Agarwal AM, Perkins SL, Salama ME (2014) Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm. Mod Pathol 27:1137\u20131143","journal-title":"Mod Pathol"},{"key":"2176_CR56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1309\/AJCP9IS9KFSVWKGH","volume":"137","author":"DM Cronin","year":"2012","unstructured":"Cronin DM, George TI, Reichard KK, Sundram UN (2012) Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm. Am J Clin Pathol 137:367\u2013376","journal-title":"Am J Clin Pathol"},{"key":"2176_CR57","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/PAS.0000000000000156","volume":"38","author":"F Julia","year":"2014","unstructured":"Julia F, Dalle S, Duru G, Balme B, Vergier B, Ortonne N, Vignon-Pennamen MD, Costes-Martineau V, Lamant L, Dalac S, Delattre C, Dechelotte P, Courville P, Carlotti A, De Muret A, Fraitag S, Levy A, Mitchell A, Petrella T (2014) Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients. Am J Surg Pathol 38:673\u2013680","journal-title":"Am J Surg Pathol"},{"key":"2176_CR58","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ccell.2016.10.002","volume":"30","author":"M Ceribelli","year":"2016","unstructured":"Ceribelli M, Hou ZE, Kelly PN, Huang DW, Wright G, Ganapathi K, Evbuomwan MO, Pittaluga S, Shaffer AL, Marcucci G, Forman SJ, Xiao W, Guha R, Zhang X, Ferrer M, Chaperot L, Plumas J, Jaffe ES, Thomas CJ, Reizis B, Staudt LM (2016) A druggable TCF4- and BRD4-dependent transcriptional network sustains malignancy in blastic plasmacytoid dendritic cell neoplasm. Cancer Cell 30:764\u2013778","journal-title":"Cancer Cell"},{"key":"2176_CR59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2010.08556.x","volume":"153","author":"F Jardin","year":"2011","unstructured":"Jardin F, Ruminy P, Parmentier F, Troussard X, Vaida I, Stamatoullas A, Lepretre S, Penther D, Duval AB, Picquenot JM, Courville P, Capiod JC, Tilly H, Bastard C, Marolleau JP (2011) TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm. Br J Haematol 153:413\u2013416","journal-title":"Br J Haematol"},{"key":"2176_CR60","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ajh.23567","volume":"88","author":"K Alayed","year":"2013","unstructured":"Alayed K, Patel KP, Konoplev S, Singh RR, Routbort MJ, Reddy N, Pemmaraju N, Zhang L, Shaikh AA, Aladily TN, Jain N, Luthra R, Medeiros LJ, Khoury JD (2013) TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow. Am J Hematol 88:1055\u20131061","journal-title":"Am J Hematol"},{"key":"2176_CR61","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/leu.2013.283","volume":"28","author":"J Menezes","year":"2014","unstructured":"Menezes J, Acquadro F, Wiseman M, Gomez-Lopez G, Salgado RN, Talavera-Casanas JG, Buno I, Cervera JV, Montes-Moreno S, Hernandez-Rivas JM, Ayala R, Calasanz MJ, Larrayoz MJ, Brichs LF, Gonzalez-Vicent M, Pisano DG, Piris MA, Alvarez S, Cigudosa JC (2014) Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm. Leukemia 28:823\u2013829","journal-title":"Leukemia"},{"key":"2176_CR62","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.18632\/oncotarget.2223","volume":"5","author":"A Stenzinger","year":"2014","unstructured":"Stenzinger A, Endris V, Pfarr N, Andrulis M, Johrens K, Klauschen F, Siebolts U, Wolf T, Koch PS, Schulz M, Hartschuh W, Goerdt S, Lennerz JK, Wickenhauser C, Klapper W, Anagnostopoulos I, Weichert W (2014) Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm. Oncotarget 5:6404\u20136413","journal-title":"Oncotarget"},{"key":"2176_CR63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature09639","volume":"469","author":"I Varela","year":"2011","unstructured":"Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, Davies H, Jones D, Lin ML, Teague J, Bignell G, Butler A, Cho J, Dalgliesh GL, Galappaththige D, Greenman C, Hardy C, Jia M, Latimer C, Lau KW, Marshall J, McLaren S, Menzies A, Mudie L, Stebbings L, Largaespada DA, Wessels LF, Richard S, Kahnoski RJ, Anema J, Tuveson DA, Perez-Mancera PA, Mustonen V, Fischer A, Adams DJ, Rust A, Chan-on W, Subimerb C, Dykema K, Furge K, Campbell PJ, Teh BT, Stratton MR, Futreal PA (2011) Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma. Nature 469:539\u2013542","journal-title":"Nature"},{"key":"2176_CR64","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/leu.2014.64","volume":"28","author":"MR Sapienza","year":"2014","unstructured":"Sapienza MR, Fuligni F, Agostinelli C, Tripodo C, Righi S, Laginestra MA, Pileri A Jr, Mancini M, Rossi M, Ricci F, Gazzola A, Melle F, Mannu C, Ulbar F, Arpinati M, Paulli M, Maeda T, Gibellini D, Pagano L, Pimpinelli N, Santucci M, Cerroni L, Croce CM, Facchetti F, Piccaluga PP, Pileri SA (2014) Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition. Leukemia 28:1606\u20131616","journal-title":"Leukemia"},{"key":"2176_CR65","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2133.2009.09373.x","volume":"162","author":"S Dalle","year":"2010","unstructured":"Dalle S, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dompmartin A, d'Incan M, Maubec E, Grange F, Dereure O, Prey S, Barete S, Wetterwald M, Fraitag S, Petrella T (2010) Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol 162:74\u201379","journal-title":"Br J Dermatol"},{"key":"2176_CR66","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3324\/haematol.2012.072645","volume":"98","author":"L Pagano","year":"2013","unstructured":"Pagano L, Valentini CG, Pulsoni A, Fisogni S, Carluccio P, Mannelli F, Lunghi M, Pica G, Onida F, Cattaneo C, Piccaluga PP, Di Bona E, Todisco E, Musto P, Spadea A, D'Arco A, Pileri S, Leone G, Amadori S, Facchetti F (2013) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica 98:239\u2013246","journal-title":"Haematologica"},{"key":"2176_CR67","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1158\/2159-8290.CD-16-0999","volume":"7","author":"J Montero","year":"2016","unstructured":"Montero J, Stephansky J, Cai T, Griffin GK, Cabal-Hierro L, Togami K, Hogdal LJ, Galinsky I, Morgan EA, Aster JC, Davids MS, LeBoeuf NR, Stone RM, Konopleva M, Pemmaraju N, Letai A, Lane AA (2016) Blastic plasmacytoid dendritic cell neoplasm is dependent on BCL2 and sensitive to venetoclax. Cancer Discov 7:156\u2013164","journal-title":"Cancer Discov"},{"key":"2176_CR68","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.V97.5.1241","volume":"97","author":"F Geissmann","year":"2001","unstructured":"Geissmann F, Lepelletier Y, Fraitag S, Valladeau J, Bodemer C, Debre M, Leborgne M, Saeland S, Brousse N (2001) Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 97:1241\u20131248","journal-title":"Blood"},{"key":"2176_CR69","doi-asserted-by":"crossref","unstructured":"Redd L, Schmelz M, Burack WR, Cook JR, Day AW, Rimsza LM (2016) Langerhans cell histiocytosis shows distinct cytoplasmic expression of major histocompatibility class II antigens. J Hamatopathol:107\u2013112","DOI":"10.1007\/s12308-016-0272-9"},{"key":"2176_CR70","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/BF01957571","volume":"151","author":"M Paulli","year":"1992","unstructured":"Paulli M, Locatelli F, Kindl S, Boveri E, Facchetti F, Porta F, Rosso R, Nespoli L, Magrini U (1992) Sinus histiocytosis with massive lymphoadenopathy (Rosai-Dorfman disease). Clinico-pathological analysis of a paediatric case. Eur J Pediatr 151:672\u2013675","journal-title":"Eur J Pediatr"},{"key":"2176_CR71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00401-011-0841-z","volume":"122","author":"D Capper","year":"2011","unstructured":"Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G, Pusch S, Mechtersheimer G, Zentgraf H, von Deimling A (2011) Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol 122:11\u201319","journal-title":"Acta Neuropathol"},{"key":"2176_CR72","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/PAS.0000000000000129","volume":"38","author":"AC Roden","year":"2014","unstructured":"Roden AC, Hu X, Kip S, Parrilla Castellar ER, Rumilla KM, Vrana JA, Vassallo R, Ryu JH, Yi ES (2014) BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol 38:548\u2013551","journal-title":"Am J Surg Pathol"},{"key":"2176_CR73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.humpath.2015.12.029","volume":"52","author":"K Alayed","year":"2016","unstructured":"Alayed K, Medeiros LJ, Patel KP, Zuo Z, Li S, Verma S, Galbincea J, Cason RC, Luthra R, Yin CC (2016) BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases. Hum Pathol 52:61\u201367","journal-title":"Hum Pathol"},{"key":"2176_CR74","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.semdp.2015.02.010","volume":"32","author":"LL Ritterhouse","year":"2015","unstructured":"Ritterhouse LL, Barletta JA (2015) BRAF V600E mutation-specific antibody: a review. Semin Diagn Pathol 32:400\u2013408","journal-title":"Semin Diagn Pathol"},{"key":"2176_CR75","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0046-8177(86)80091-0","volume":"17","author":"MP Neumann","year":"1986","unstructured":"Neumann MP, Frizzera G (1986) The coexistence of Langerhans\u2019 cell granulomatosis and malignant lymphoma may take different forms: report of seven cases with a review of the literature. Hum Pathol 17:1060\u20131065","journal-title":"Hum Pathol"},{"key":"2176_CR76","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/1097-0142(19930201)71:3<865::AID-CNCR2820710334>3.0.CO;2-0","volume":"71","author":"RM Egeler","year":"1993","unstructured":"Egeler RM, Neglia JP, Puccetti DM, Brennan CA, Nesbit ME (1993) Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 71:865\u2013873","journal-title":"Cancer"},{"key":"2176_CR77","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/ajcp\/104.6.696","volume":"104","author":"MA Vasef","year":"1995","unstructured":"Vasef MA, Zaatari GS, Chan WC, Sun NC, Weiss LM, Brynes RK (1995) Dendritic cell tumors associated with low-grade B-cell malignancies. Report of three cases. Am J Clin Pathol 104:696\u2013701","journal-title":"Am J Clin Pathol"},{"key":"2176_CR78","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1080\/10428190500160017","volume":"46","author":"MM Trebo","year":"2005","unstructured":"Trebo MM, Attarbaschi A, Mann G, Minkov M, Kornmuller R, Gadner H (2005) Histiocytosis following T-acute lymphoblastic leukemia: a BFM study. Leuk Lymphoma 46:1735\u20131741","journal-title":"Leuk Lymphoma"},{"key":"2176_CR79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humpath.2005.08.024","volume":"37","author":"LJ Christie","year":"2006","unstructured":"Christie LJ, Evans AT, Bray SE, Smith ME, Kernohan NM, Levison DA, Goodlad JR (2006) Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon? Hum Pathol 37:32\u201339","journal-title":"Hum Pathol"},{"key":"2176_CR80","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.2011.102","volume":"24","author":"H Shao","year":"2011","unstructured":"Shao H, Xi L, Raffeld M, Feldman AL, Ketterling RP, Knudson R, Rodriguez-Canales J, Hanson J, Pittaluga S, Jaffe ES (2011) Clonally related histiocytic\/dendritic cell sarcoma and chronic lymphocytic leukemia\/small lymphocytic lymphoma: a study of seven cases. Mod Pathol 24:1421\u20131432","journal-title":"Mod Pathol"},{"key":"2176_CR81","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.path.2013.08.003","volume":"6","author":"AL Feldman","year":"2013","unstructured":"Feldman AL (2013) Clonal relationships between malignant lymphomas and histiocytic\/dendritic cell tumors. Surg Pathol Clin 6:619\u2013629","journal-title":"Surg Pathol Clin"},{"key":"2176_CR82","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00428-015-1814-8","volume":"467","author":"MR Ambrosio","year":"2015","unstructured":"Ambrosio MR, De Falco G, Rocca BJ, Barone A, Amato T, Bellan C, Lazzi S, Leoncini L (2015) Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity. Virchows Arch 467:471\u2013480","journal-title":"Virchows Arch"},{"key":"2176_CR83","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00428-010-0931-7","volume":"457","author":"D Benharroch","year":"2010","unstructured":"Benharroch D, Guterman G, Levy I, Shaco-Levy R (2010) High content of Langerhans cells in malignant lymphoma\u2014incidence and significance. Virchows Arch 457:63\u201367","journal-title":"Virchows Arch"},{"key":"2176_CR84","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4103\/1947-2714.114172","volume":"5","author":"W Chen","year":"2013","unstructured":"Chen W, Jaffe R, Zhang L, Hill C, Block AM, Sait S, Song B, Liu Y, Cai D (2013) Langerhans cell sarcoma arising from chronic lymphocytic lymphoma\/small lymphocytic leukemia: lineage analysis and BRAF V600E mutation study. N Am J Med Sci 5:386\u2013391","journal-title":"N Am J Med Sci"},{"key":"2176_CR85","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/pbc.25523","volume":"62","author":"J Alten","year":"2015","unstructured":"Alten J, Klapper W, Leuschner I, Eckert C, Beier R, Vallo E, Krause M, Claviez A, Vieth S, Bleckmann K, Moricke A, Schrappe M, Cario G (2015) Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 62:1656\u20131660","journal-title":"Pediatr Blood Cancer"},{"key":"2176_CR86","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.humpath.2016.04.004","volume":"55","author":"S Fernandez-Pol","year":"2016","unstructured":"Fernandez-Pol S, Bangs CD, Cherry A, Arber DA, Gratzinger D (2016) Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma. Hum Pathol 55:39\u201343","journal-title":"Hum Pathol"},{"key":"2176_CR87","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0092-8674(04)00419-2","volume":"117","author":"H Xie","year":"2004","unstructured":"Xie H, Ye M, Feng R, Graf T (2004) Stepwise reprogramming of B cells into macrophages. Cell 117:663\u2013676","journal-title":"Cell"},{"key":"2176_CR88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ejh.12755","volume":"97","author":"J Ansari","year":"2016","unstructured":"Ansari J, Naqash AR, Munker R, El-Osta H, Master S, Cotelingam JD, Griffiths E, Greer AH, Yin H, Peddi P, Shackelford RE (2016) Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment. Eur J Haematol 97:9\u201316","journal-title":"Eur J Haematol"},{"key":"2176_CR89","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1200\/JCO.2013.49.0078","volume":"32","author":"D Michonneau","year":"2014","unstructured":"Michonneau D, Kaltenbach S, Derrieux C, Trinquand A, Brouzes C, Gibault L, North MO, Delarue R, Varet B, Emile JF, Brousse N, Hermine O (2014) BRAF (V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia. J Clin Oncol 32:e117\u2013e121","journal-title":"J Clin Oncol"},{"key":"2176_CR90","doi-asserted-by":"crossref","first-page":"78355","DOI":"10.18632\/oncotarget.13058","volume":"7","author":"W Huang","year":"2016","unstructured":"Huang W, Qiu T, Zeng L, Zheng B, Ying J, Feng X (2016) High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms. Oncotarget 7:78355\u201378362","journal-title":"Oncotarget"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-017-2176-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T18:09:41Z","timestamp":1602439781000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-017-2176-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,10]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["2176"],"URL":"https:\/\/doi.org\/10.1007\/s00428-017-2176-1","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,10]]}}}